Matchpoint: a toolkit to create covalent therapies for immunology

Timmerman Report: Matchpoint gets $100 Million to Take Covalent Binders in Autoimmune Disease

Boston Business Journal: Sanofi backs $100M round for startup targeting immune system diseases

Biospace: Sanofi-Backed Matchpoint Launches with $100M for Precision Covalent Medicines - Updated

Dana-Farber Cancer Institute launches investment fund to support startup companies